1[1]Sen S,Tarazi RC,Bumpus FM.Cardiac hypertrophy and anti-hypertensive therapy.Cardiovasc Res,1997,11:427
2[2]Olivetti G,Giordano G,Corradi D,et al.Gender differences and aging:effects on the human heart.J Am Coll Cardiol,1995,26:1068
3[3]De Simone G,Devereux R,Daniels SR,et al.Effect of growth on variability of left ventricular mass:assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.J Am Coll Cardiol,1995,25:1056
4[4]Giorgio O,Elena C,Roberta M,et al.Recent advances in cardiac hypertrophy.Cardiovasc Res,2000,45:68
5[5]Beltrami CA,Finato N,Rocco M,et al.The cellular basis of dilated cardiomyopathy in humans.J Mol Cell Cardiol,1995,27:291
6[6]Dipla K,Mattiello JA,Jeevanandam V,et al.Myocyte recovery alters mechanical circulatory support in humans with end-stage heart failure.Circulation,1998,97:2316
7[7]Olivetti G,Abbi R,Quaini F,et al.Apoptosis in the failing human heart.N Engl J Med,1997,336:1131
8[8]Kajstura J,Cheng W,Sarangangarajan R,et al.Necrotic and apoptotic myocyte cell death in the aging heart of Fisher 344 rats.Am J Physiol,1996,271:1215
9Fathi R,Marwick TH.Noninvasive tests of vascular function and structure: why and how to perform them[].American Heart Journal.2001
10Crouse JR,Harpold GH,Kahl FR,et al.Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound[].Stroke.1986
